Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
Has Results
  • Breast Cancer
  • Mobile, Alabama
  • +437 more
Mar 21, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • PY314
  • Combination Therapy: PY314 + Pembrolizumab
  • Scottsdale, Arizona
  • +12 more
Mar 28, 2022

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022

Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +84 more
Mar 15, 2022

Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

Terminated
Has Results
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Tucson, Arizona
  • +53 more
Feb 24, 2022

NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in United States (JAB-3312)

Recruiting
  • Non-small Cell Lung Cancer
  • +6 more
  • Denver, Colorado
  • +3 more
Mar 13, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

Active, not recruiting
Has Results
  • HER-2 Positive Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +3 more
Mar 4, 2022

Solid Tumor, Glioblastoma, NSCLC Trial in Nashville, Houston, Villejuif (TAS2940)

Recruiting
  • Solid Tumor
  • +3 more
  • Nashville, Tennessee
  • +2 more
Feb 25, 2022

Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

Active, not recruiting
  • Breast Cancer
  • San Diego, California
  • +23 more
Feb 17, 2022

Breast Cancer Trial in United States (Margetuximab)

Completed
Has Results
  • Breast Cancer
  • Margetuximab
  • San Francisco, California
  • +5 more
Feb 4, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

Completed
  • Breast Cancer
  • +5 more
  • Nashville, Tennessee
  • +11 more
Jan 28, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (DS-8201a)
  • +5 more
  • Chandler, Arizona
  • +207 more
Jan 25, 2022

Breast Cancer Trial in Nashville (Chlorhexidine irrigation, triple antibiotic irrigation)

Completed
Has Results
  • Breast Cancer
  • Chlorhexidine irrigation
  • triple antibiotic irrigation
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 22, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +611 more
Jan 21, 2022

Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)

Active, not recruiting
Has Results
  • Breast Cancer
  • pegfilgrastim
  • +4 more
  • Anniston, Alabama
  • +541 more
Jan 19, 2022

Breast Cancer Trial in United States (Bevacizumab, Cyclophosphamide, Methotrexate)

Terminated
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +8 more
Dec 20, 2021

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

Completed
  • Breast Cancer
  • +3 more
  • FPA150
  • Pembrolizumab
  • Scottsdale, Arizona
  • +17 more
Jan 6, 2022

Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)

Completed
  • Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • Denver, Colorado
  • +2 more
Dec 14, 2021

Breast Cancer Trial in Nashville (breast biopsy, histopathologic examination, light-scattering spectroscopy)

Recruiting
  • Breast Cancer
  • breast biopsy
  • +3 more
  • Nashville, Tennessee
  • +2 more
Dec 6, 2021